STXS Stereotaxis, Inc.: Operating Margin

Corporate emblem and logo of Stereotaxis Corporation (STXS)

Stereotaxis, Inc. (STXS) dynamics depend on the adoption rate of magnetic navigation in clinics. The EBIT margin confirms this hypothesis, where the value -67.80 reflects the metric's balance. Stability is provided by the sale of disposable catheters and maintenance services. However, system costs and the risk of failures limit expansion, which constrains the company's overall revenue growth rates.

STXS: Stereotaxis Operating Margin 07/04/2022 - 11/19/2026

Stereotaxis, Inc. - analytical breakdowns and key metrics (STXS)

- share price and consensus valuation forecast:
Fundamental company analysis:STXS, Stereotaxis Inc
Brand item of Stereotaxis Corporation

Stereotaxis, Inc. (STXS) is developing a high-tech business focused on implementing robotic magnetic navigation systems in cardiac surgery. This metric is calculated as the ratio of operating profit to revenue, measuring cost management efficiency. An analysis of the EBIT margin allows for an assessment of the brand's ability to convert its technological advantage into actual income. Sharp peaks in the EBIT margin may signal an asset overvaluation. Investors should be wary of extreme highs, which are fraught with a subsequent price correction.

Competitors of Stereotaxis, Inc. (STXS)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)